According to Ars Technica, Cost and access barriers are pushing people to modified use and unapproved versions.
Millions of Americans are not taking their GLP-1 drugs as prescribed
Context
The report, filed in our Tech section, was first published by Ars Technica on Friday, November 13.
Sources
Automated brief This brief was compiled automatically by a rule-based system (no AI) from the headlines, feed teasers and page summaries that the outlets above published. Each outlet's text appears in its own attributed paragraph as a short excerpt; only public-domain U.S. government releases are quoted at greater length. Background paragraphs are excerpts from Wikipedia. Nothing else is added, and crime and allegation wording is attributed to the sources. It may contain errors — the original reports are authoritative. How we work · Corrections: theopenwiresupport@protonmail.com

